Funding Rounds
Immatics Biotechnologies Series C round
Immatics BiotechnologiesImmatics Biotechnologies is a biopharmaceutical company focused on the discovery and development of immunotherapy of cancer.
Summary
Stage: Series C
Raised Amount: $70.85M
Raised Date: 2010-09-21
